Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Madeleine Zerbato
Observed name:
M Zerbato
Institution:
Novartis Gene Therapies, Inc. (United States)
Observed institutions:
Brigham and Women's Hospital,
Harvard University,
Inserm,
Genethon (France),
Harvard Stem Cell Institute,
Novartis Gene Therapies, Inc. (United States),
Université d'Évry Val-d'Essonne
show all 7
ORCID:
0000-0001-6163-1162
Observed ORCID:
0000-0001-6163-1162
OpenAlex ID:
A5013460153
Quantification of lentiviral vector copy numbers in individual hematopoietic colony-forming cells shows vector dose-dependent effects on the frequency and level of transduction
2010
·
S Charrier
, M Ferrand
, et al.
·
Gene Therapy
·
119
PDF
Transcription factor SOX15 regulates stem cell pluripotency and promotes neural fate during differentiation by activating the neurogenic gene Hes5
2023
·
Eun-Bee Choi
, Munender Vodnala
, et al.
·
Journal of Biological Chemistry
·
13
PDF
ATP-binding cassette protein ABCF1 couples transcription and genome surveillance in embryonic stem cells through low-complexity domain
2021
·
Eun-Bee Choi
, Munender Vodnala
, et al.
·
Science Advances
·
13
The Brown Algae Pl.LSU/2 Group II Intron-Encoded Protein Has Functional Reverse Transcriptase and Maturase Activities
2013
·
Madeleine Zerbato
, Nathalie Holic
, et al.
·
PLoS ONE
·
11
PDF
Unlocking patient access to gene therapy: five key practices
2024
·
Tay Salimullah
, Burcu Kazazoglu Taylor
, et al.
·
Gene Therapy
·
2
Characterization of the P1.LSU/2 group II intron for its use in genomic targeting
2012
·
Madeleine Zerbato
·
theses.fr (ABES)
Show more works
View as search
Works count:
6
Citation count:
158
H-index:
4
I10-index:
4
Year
Topic
Type